{"id":277459,"date":"2026-01-10T09:50:08","date_gmt":"2026-01-10T09:50:08","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/277459\/"},"modified":"2026-01-10T09:50:08","modified_gmt":"2026-01-10T09:50:08","slug":"obesity-ma-biotech-resurgence-a-2026-guide-to-health-stocks","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/277459\/","title":{"rendered":"Obesity, M&#038;A, Biotech Resurgence: A 2026 Guide to Health Stocks"},"content":{"rendered":"<p class=\"ArticleBodyText_articleBodyContent__17wqE typography_articleBody___5jDr\" data-component=\"paragraph\">The health-care corner of the US equity market has traditionally been viewed as defensive, thanks to steady growth and healthy dividend yields among the industry\u2019s stalwarts. That narrative is changing.<\/p>\n<p class=\"ArticleBodyText_articleBodyContent__17wqE typography_articleBody___5jDr\" data-component=\"paragraph\">Following years of underperformance relative to the broader market, health care staged a turnaround last quarter, posting the best performance among the 11 major industry groups in the S&amp;P 500 Index. <\/p>\n","protected":false},"excerpt":{"rendered":"The health-care corner of the US equity market has traditionally been viewed as defensive, thanks to steady growth&hellip;\n","protected":false},"author":2,"featured_media":277460,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[275],"tags":[7823,10948,718,18,27036,6915,135,475,474,19,54319,17,188,27038,9222,11994,992],"class_list":{"0":"post-277459","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-acquisitions","9":"tag-donald-john-trump","10":"tag-drugs","11":"tag-eire","12":"tag-eli-lilly-co","13":"tag-food-and-drug-administration","14":"tag-health","15":"tag-health-care","16":"tag-healthcare","17":"tag-ie","18":"tag-investment-management","19":"tag-ireland","20":"tag-markets","21":"tag-novo-nordisk-a-s-b","22":"tag-pharmaceutical","23":"tag-regulation","24":"tag-stocks"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/115870185694197156","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/277459","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=277459"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/277459\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/277460"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=277459"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=277459"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=277459"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}